Preclinical studies suggest that propofol may inhibit glioma cell proliferation, invasion, and migration and promote apoptosis through mechanisms such as the upregulation of microRNA-218 and suppression of HIF-1α and MMP-2 activity [8,11]. The gene discussed is HIF1A; the disease is central nervous system cancer.